2024-01-09 01:05:44 ET
DENVER, Colo., Jan. 8, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Cellectar Biosciences, Inc. (NASDAQ: CLRB), Aclarion, Inc. (NASDAQ: ACON), Ardelyx (NASDAQ: ARDX), Sidus Space Inc. (NASDAQ: SIDU), NexImmune Inc. (NASDAQ: NEXI), and C4 Therapeutics Inc. (NASDAQ: CCCC).
It seemed like most of this morning’s most active listings traded much better in the premarket, like Cellectar Biosciences (NASDAQ: CLRB), which reported positive data from its CLOVER WaM pivotal study that we covered when it was trading at $3.00, up $0.29 (+10.70%), on 301K shares traded.
Cellectar Biosciences went on to hit a premarket high of $4.84, but dropped down to a premarket low of $2.83, before recovering to open the regular trading session at $3.12, …
The post 24/7 Market News Wrap 8 Jan 2024 appeared first on 24/7 Market News .
For further details see:
24/7 Market News Wrap 8 Jan 2024
Disclaimer
This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of NexImmune Inc. (NEXI) and does not buy, sell, or trade any shares of (NEXI). This article does not provide a professional analysis of a (NEXI) financial position. (NEXI) financial position and all other information regarding the featured Company should be verified directly with (NEXI). Please read our full disclaimer for more detailed information.
